Immuno-Designed Molecules

Updated: 7/10/2006

172 rue de Charonne

75011†

Paris,

France

Phone: +33 (0) 1 40 09 04 11

Fax: +33 (0) 1 40 09 04 25

Email:

IDM develops cell-based immunotherapy pharmaceuticals.

History:

Founded in 1993. Acquired technology from Jenner Biotherapies in 2003. Merged with Epimmune in 2005 and now acts as the European operations of the newly formed IDM Pharma.

Employment

Email:flicci@idm-biotech.com

Fax:

Mail:

General Info:
Ticker: private
Employees: 124 (12/2002) Regions: Southern California Europe
Research Focus: Disease Therapeutics-Clinical late (III, IV)

Profiles:
News:

Keywords:

Strategic Partnerships: